IDYA

IDEAYA Biosciences Inc.

Price

$38.87

return (12m)

61.62%

p/e

-18.96

p/bv

2.77

DIVIDEND YIELD

0.00%

IDYA price

IDEAYA Biosciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment IDYA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

7.58%

3 months

31.58%

1 year

61.62%

2 years

-0.49%

5 years

64.08%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals IDYA

Valuation

P/E

-18.96

Sector -4.38

Industry -4.38

P/BV

2.77

Sector 2.02

Industry 2.02

P/Revenue (PSR)

14.17

Sector -4.40

Industry -4.40

EV/EBITDA

-20.55

Sector -263.09

Industry -263.09

EV/EBIT

-20.36

Sector -702.90

Industry -702.90

P/EBITDA

-15.62

Sector -4.39

Industry -4.39

P/EBIT

-15.30

Sector -4.73

Industry -4.73

P/Total Assets

2.53

Sector 1.49

Industry 1.49

P/Net Current Assets

4.41

Sector -11.70

Industry -11.70

P/Working Capital

4.25

Sector -3.19

Industry -3.19

EPS

-1.90

Sector -2.14

Industry -2.14

BVPS

13.03

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

100.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

-1,367.61%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-1,380.25%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-92.66%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-74.75%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.01

Sector 0.03

Industry 0.03

Profitability

ROE

-14.60%

Sector -65.14%

Industry -65.14%

ROA

-13.36%

Sector -65.53%

Industry -65.53%

ROIC

-125.19%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

10.45

Sector 2.90

Industry 2.90

Net Debt / EBITDA

6.84

Sector -6.07

Industry -6.07

Net Debt / EBIT

6.78

Sector -8.26

Industry -8.26

Net Debt / Equity

-0.69

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.92

Sector 0.41

Industry 0.41

Liabilities/Assets

0.08

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

52.97%

Sector -

Industry -

5Y Earnings CAGR

28.59%

Sector -

Industry -

Fundamentals IDYA

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
IDYA IDEAYA Biosciences Inc.	$38.87	57.05%	0.00%	-18.96	2.77	-14.60%	-74.75%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

IDYA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT IDEAYA Biosciences

IDEAYA Biosciences Inc.

Average Investor10 user rating

4.0 (0 people)

United States

11 years

Founded: 2015

2019

Time since IPO - 7 years

62

Employees

IDEAYA Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $3.32 billion, with shareholders equity totaling $1.20 billion.

The company employs approximately 62 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, IDEAYA Biosciences Inc. reported $234.13 million in revenue, generating net income of $-175.02 million.

Key financial metrics include a P/E ratio of -18.96, a price-to-book (P/B) ratio of 2.77, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker IDYA.

Market cap

$3.32 billion

Net worth

$1.20 billion

$1,198,900,000.00

Assets

$1.31 billion

$1,309,700,000.00

Total Shares Outstanding

92.00 million

92,000,000

Average Daily Trading Volume

$1.15 million

$1,149,402.00

Sector

Health Care

Industry

Biotechnology

IDYA

IDYA revenue and profits

Financial Results IDYA

DRAG THE FRAME TO SEE MORE DATA

IDYA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of IDEAYA Biosciences (IDYA) today?

A cotação de IDEAYA Biosciences (IDYA) hoje está em US$ 38.87, com uma variação de 61.62% em relação ao último ano. A cotação de IDEAYA Biosciences (IDYA) iniciou o ano negociando na casa dos US$ 34.57 e hoje está em US$ 38.87. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de IDEAYA Biosciences (IDYA) e dados de ações do Ibovespa e mercados internacionais.

Quando IDEAYA Biosciences (IDYA) paga dividendos?

IDEAYA Biosciences (IDYA) não distribuiu dividendos no último ano.

Is IDEAYA Biosciences (IDYA) a good investment?

Atualmente, IDEAYA Biosciences (IDYA) está cotada a US$ 38.87, com um P/L de -18.96, representando um desvio de -1,789% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 61.62 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 61.62%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy IDEAYA Biosciences (IDYA) stock?

Investir em ações de IDEAYA Biosciences (IDYA) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of IDEAYA Biosciences (IDYA) yield today?

A rentabilidade de IDEAYA Biosciences (IDYA) foi de 7.58% no último mês, 61.62% no último ano e 64.08% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de IDEAYA Biosciences (IDYA) hoje, o investimento total seria de US$ 3,887.00, com base na cotação atual de US$ 38.87.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 6,282.17
Em 5 anos: US$ 6,377.79
Em 10 anos: US$ 3,887.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

IDYA

IDEAYA Biosciences Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment IDYA

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING IDYA WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT IDEAYA Biosciences

IDEAYA Biosciences Inc.

United States

11 years

2019

62

PROFIT X PRICE IDYA

Financial Results IDYA

IDYA cash flow

Asset, Revenue and Profit Growth - IDYA

IDYA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions